Medtronic begins two Symplicity renal denervation system clinical initiatives

Medtronic, Inc. (NYSE: MDT) announced today the start of two clinical initiatives evaluating the broader, real-world clinical use of the company's Symplicity™ renal denervation system across multiple conditions. Furthering its leadership in the development of renal denervation therapy, Medtronic launched the Global SYMPLICITY Patient Registry, which will evaluate the real-world, long-term impact of renal denervation in more than 5,000 patients, as well as SYMPLICITY-HF, the first clinical trial to examine renal denervation in patients with chronic heart failure and renal impairment.

Renal denervation therapy is a minimally invasive, catheter-based procedure that modulates the output of nerves that line the walls of the arteries leading to the kidneys. These nerves impact the sympathetic nervous system, which affects the major organs that are responsible for regulating blood pressure: the brain, the heart, the kidneys and the blood vessels.

"These research initiatives represent part of Medtronic's broad commitment to partner with the medical community to explore the use of renal denervation in a number of disease states characterized by hyperactive sympathetic nervous system drive," said Sean Salmon, Senior Vice President and President, Coronary & Renal Denervation, Medtronic. "Data from the Global SYMPLICITY Registry and the SYMPLICITY-HF clinical trial will build upon the substantial renal denervation data Medtronic has generated in patients with treatment-resistant hypertension to date."

Source:

Medtronic, Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Medtronic. (2019, June 17). Medtronic begins two Symplicity renal denervation system clinical initiatives. News-Medical. Retrieved on May 28, 2022 from https://www.news-medical.net/news/20120213/Medtronic-begins-two-Symplicity-renal-denervation-system-clinical-initiatives.aspx.

  • MLA

    Medtronic. "Medtronic begins two Symplicity renal denervation system clinical initiatives". News-Medical. 28 May 2022. <https://www.news-medical.net/news/20120213/Medtronic-begins-two-Symplicity-renal-denervation-system-clinical-initiatives.aspx>.

  • Chicago

    Medtronic. "Medtronic begins two Symplicity renal denervation system clinical initiatives". News-Medical. https://www.news-medical.net/news/20120213/Medtronic-begins-two-Symplicity-renal-denervation-system-clinical-initiatives.aspx. (accessed May 28, 2022).

  • Harvard

    Medtronic. 2019. Medtronic begins two Symplicity renal denervation system clinical initiatives. News-Medical, viewed 28 May 2022, https://www.news-medical.net/news/20120213/Medtronic-begins-two-Symplicity-renal-denervation-system-clinical-initiatives.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
Landmark stroke studies presented at ISC, published in NEJM suggest new treatment protocol on the horizon